Cartesian Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $22.5M | $114.1M |
| FY2022 | — | $93.8M | $106.4M |
| FY2023 | — | $-440.2M | $76.9M |
| FY2024 | — | $-6.8M | $212.6M |
| FY2025 | — | $-126.2M | $125.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $22.5M | $114.1M |
| FY2022 | — | $93.8M | $106.4M |
| FY2023 | — | $-440.2M | $76.9M |
| FY2024 | — | $-6.8M | $212.6M |
| FY2025 | — | $-126.2M | $125.1M |